Necrobiosis Lipoidica

Česká verzia

Authors: J. Nováková
Authors place of work: Kožní oddělení FN Ostrava a LF OU Ostrava, vedoucí pracoviště prim. MUDr. Yvetta Vantuchová, Ph. D.
Published in the journal: Čes-slov Derm, 96, 2021, No. 2, p. 59-69
Category: Reviews (Continuing Medical Education)

Summary

Necrobiosis lipoidica je chronické granulomatózní onemocnění kůže, které bývá sdruženo s diabetem nebo glukózovou intolerancí. Etiologie nemoci není jasná, nejčastěji se zvažuje zásadní role mikroangiopatie. Typickým projevem jsou červenohnědé ploché papuly na přední straně bérců splývající v plošná atrofická ložiska s teleangiektaziemi. Komplikací může být vznik ulcerace v ložisku. Diagnóza se stanoví podle klinického obrazu a případného histologického vyšetření. Léčba necrobiosis lipoidica je neuspokojivá nejsou k dispozici přijaté léčebné postupy. Článek poskytuje současný přehled léčebných metod této nemoci.

Keywords:

necrobiosis lipoidica – etiopathogenesis – diagnostics – treatment – diabetes mellitus

Zdroje

1. ARAGHI, F., TABARY, M., RAKHSAN, A. et al. Necrobiosis lipoidica – like lesions in a nondiabetic patient with systemic sarcoidosis: A case report and review of the literature. Clinical Case Reports, 2020.

2. BALL, S. L., SALMON, N. J., TIDMAN, M. J. Treatment of necrobiosis lipoidica with intra-lesional glucocorticoid. Brit J Diab., 2018, 18(3), p. 122–123.

3. BAROUTI, N., CAO, A. Q., FERRARA, D., PRINS, CH. Succesful treatment of ulcerative and diabeticorum necrobiosis lipoidica with intravenous immunoglobulin in a patient with Common Variable Immunodeficiency. JAMA Derm., 2013, 149(7), p. 879–881.

4. BATCHELOR, J. M., TODD, P. M. Treatment of ulcerated necrobiosis lipoidica with intravenous immunoglobulin and methylprednisolon. J Drug Dermatol., 2012, 111(2), p. 256–259.

5. BEATTIE, P. E., DAWE, R. S., IBBOTSON, S. H. et al. UVA1 phototherapy for treatment of necrobiosis lipoidica. Clin Exp Dermatol., 2006, 31(2), p. 21.

6. BERGQVIST, E., BERGQVIST, G. The long- term effect of pulsed dye laser on necrobiosis lipoidica: A case study. Journal of Cosmetic and Laser Therapy, 2019, 21(1), p. 17–18.

7. BOUHANICK, B., VERRET, J. L., GOUELLO, J. P. et al. Necrobiosis lipoidica: Treatment by hyperbaric oxygen and local corticosteroids. Diabetes and Metabolism, 1998, 24(2), p. 156–159.

8. BURNS, E., UKOHA, U., CHAN, A. Necrobiosis lipoidica with rapid response to doxycycline. Pediatric Dermatology, 2020, 37(5), p. 981–982.

9. CHAN, S. A., THOMAS, M., SNEAD, D. Penile necrobiosis lipoidica: A case report and literature rewiew. Clin Exp Dermatol., 2018, 44(4), p. 441–443.

10. CHANDAN, N., JERDAN, K., TSOUKAS, M. et al. Sarkoidosis with cutaneous manifestations of necrobiosis lipoidica. Am Jour Dermatopathol., 2020, 42(4), p. 308–311.

11. DARVAY, A., ACLAND, K. M., RUSSEL-JONES, R. Perzistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin. Br J Dermatol., 1999, 141, p. 725–727.

12. DURUPT, F., DALLE, S., DEBARBIEUX, S. et al. Successful treatment of necrobiosis lipoidica with antimalar agents. Arch Dermatol., 2008, 144, p. 118–119.

13. ERFURT-BERGE, C., DISSEMOND, J., SCHWEDE, K. et al. Updated results of 100 patients on clinical and therapeutic options in necrobiosis lipoidica in a retrospective multicentre study. Eur. J. Derm., 2015, 26(6) p. 595–601.

14. FIALOVÁ, P., VAŠKŮ, V. PDT a možnosti jejího využití v dermatologii. Dermatologie pro praxi, 2017, 11(4), p. 166–169.

15. GEBAUER, K.,ARMSTRON, M. Koebner phemomenon with necrobiosis lipoidica diabeticorum. Inter Journ Derm., 1993, 23(12), p. 895–896.

16. GINOCCHIO, I., DRAGHI, L., DARVISHIAN, F. et al. Refractory ulcerated necrobiosis lipoidica: Closure of a difficult wound with topical tacrolimus. Adv Skin Wound Care, 2017, 30(10), p. 469–472.

17. GORI, N., DI STEFANI, A., DE LUCA, E. V. et al. A case of disseminated perforating necrobiosis lipoidica. Clin Case Rep., 2020, 8, p. 808–810.

18. GRIFFITHS, CH., BARKER, J., BLEIKER, T. et al. Rooks Textbook of Dermatology, 2017, Vol. III, 9 th Edition. p. 97.8–97.11.

19. HAMMER, E., LILIENTHAL, E., HOFER, S. E. et al. Risk factors for necrobiosis lipoidica in type I diabetes mellitus. Diabetic Medicine, 2017, 34(1), p. 86–92.

20. HANDFIELD-JONES, S., PEACHEY, R. High dose nicotinamide in the treatment of necrobiosis lipodicia. Br JDerm., 1988, 118, p. 693–696.

21. HASHEMI, D. A., BROWN-JOEL, Z. O., TKACHENKO, E. Clinical features and comorbidities of patients with necrobiosis lipoidica with or without diabetes. JAMA Derm., 2019, 155(4), p. 455–459.

22. IRVINE, A. D., HOEGER, P. H., YAN, A. C. Harpers Text-book of Dermatology, 2012, Third Edition, Vol III, p. 172.22.

23. JEAN-LOIC, M., ODILE, R. Treatment of necrobiosis lipodica with 595 nm pulsed laser- a case report. Open Der Jour., 2008, 2, p. 22–25.

24. KAAE, J., PHILIPSEN, P. A., WULF, H. CH. Photodynamic therapy of necrobiosis lipoidica using methyl aminolevulate: A retrospective follow-up study. Photodiagnosis and Photodynamic Ther., 2018, 22, p. 223–226.

25. KOURA-NISHIURA, A.,YONEDA, K., NAKAI, K. Clearence of atypical facial necrobiosis lipoidica with tacrolimus ointement. JEADV, 2016, 30(2), p. 833–385.

26. KREUTER, A., KNIERIM, C., STUCKER, M. et al. Fumaric acid esters in necrobiosis lipoidica: results of prospective noncontolled study. Br J Dermatol., 2005, 153(4), p. 802–807.

27. KUKREJA, T., PETERSEN, J. Thalidomide for treat-ment of refractory necrobiosis lipoidica. Arch Dermatol., 2006, 142(1), p. 20–22.

28. MEISSNER, M., VALESKY, E. M., KIPPENBERGER, S. et al. Dimethyl fumarate – only anti-psoriatic medication? JDDG, 2012, 10, p. 793–801.

29. MENSING, H. Clofazimine – therapeutic alternative in necrobiosis lipoidica and granuloma annulare. Hautarzt, 1989, 40, p. 99–103.

30. MISTRY, B. D., ALAVI, A., ALI, S. A systematic review of the relationship between glycemic control and necrobiosis lipoidica diabeticorum in patiens with diabetes mellitus. Int Jour Derm., 2017, 56(12), p. 1319–1327.

31. MULLER, S. A., WINKELMANN, R. K. Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases. Arch Dermatol., 1966, 93, p. 272–281.

32. PECKRUHN, M., TITTELBACH, J., ELSNER, P. Update: Treatment of necrobiosis lipoidica. Deutsche Dermatologic Gesellschaft, 2017, p. 151–157.

33. PETZELBAUER, P., WOLFF, K., TAPPEINER, G. Necrobiosis lipoidica: treatment with systemic cortico-steroids. Brit Jour Derm., 1992, 126, p. 542–545.

34. REID, S. D., LADIZINSKI, B., LEE, K. Update on necrobiosis lipoidica: A review of etiology, diagnosis, and treatment. J Am Acad Dermatol., 2013, 69(5), p. 783–791.

35. RODENAS-HERRANZ, T., LINARES-GONZÁLEZ, L. L., ESPAŇA, R. R. Pancreas-kidney transplantation resolves chronic necrobiosis lipoidica: A case report. Derm Ther., 2020, 33(4), p. e 13484.

36. SANDHU, J. K., ALAVI, A. The role of anti-tumor necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and reiew of the literature. JCMS Case Report, 2019, 7, p. 1–5.

37. SCHIMANOVICH, I., ERDMANN, H., GRABBE, J. Necrobiosis lipoidica in monozygotic twins. JAMA Derm., 2008, 144(1), p. 119–120.

38. SEVERSON, K., XIE, D., CHA, S. et al. 338 Necrobiosis lipoidica comorbidities and complications. Jour Invest Derm., 2018, 138(5), p. 557.

39. STANWAY, A., RADEMAKER, M., NEWMAN, P. Healing of severe ulcerative necrobiosis lipoidica with cyklosporin. Australas JDerm., 2004, 45(2), 1, p. 119–122.

40. STATHAM, B., FINALY, A. Y., MARKS, R. A randomized double blind comparsion of an aspirin dipyrimadol combination versus a placebo in the treatment of necrobiosis lipoidica. Acta Derm Venereol., 1981, 61, p. 270–271.

41. TAPPEINER, G. Necrobiosis lipoidica: treatment with systemic corticosteroids. Br J Dermatol., 1992, 126, p. 542–545.

42. UVA, L., FREITAS, J., SOARES DE ALMEIDA, L. et al. Squamous cell carcinoma arising in ulcerated necrobiosis lipoidica diabeticorum. Inter Wound Jour., 2015, 12(6), p. 741–743.

43. YASAR, S., KAYNAK, E., GUNES, P. et al. Atypical localisation of Necrobiosis Lipoidica: Involvement of the Face and Scalp. Skin Appendage Disord., 2017, 3, p. 92–94.

44. WANAT, K., ROSENBACH, M. Necrobiosis lipoidica. 2018, Uptodate.com.

45. WEE, E., KELLY, R. Penoxyfylline: An effective therapy for necrobiosis lipoidica. Australasian J Derm., 2015, 58(1), p. 65–68.

46. WEISZ, G., RAMON, Y., WAISMAN, D. et al. Treatment of necrobiosis lipoidica by hyperbaric oxygen. Act Derm Vener., 1993, 73(6) p. 447–448.